Terms: = Lung cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Prognosis
26 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2.
Wang FM; Xu LQ; Zhang ZC; Guo Q; Du ZP; Lei Y; Han X; Wu CY; Zhao F; Chen JL
Aging (Albany NY); 2024 Jan; 16(2):1605-1619. PubMed ID: 38244585
[TBL] [Abstract] [Full Text] [Related]
3. The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.
Zhang J; Zhao R; Xu H; Dong L; Chen X
Ann Diagn Pathol; 2023 Dec; 67():152192. PubMed ID: 37639838
[TBL] [Abstract] [Full Text] [Related]
4. Percutaneous Radiofrequency Ablation of Thyroid Carcinomas Ineligible for Surgery, in the elderly.
Marcy PY; Tassart M; Marchand JG; Thariat J; Bizeau A; Ghanassia E
Curr Oncol; 2023 Aug; 30(8):7439-7449. PubMed ID: 37623020
[TBL] [Abstract] [Full Text] [Related]
5. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract] [Full Text] [Related]
6. NIR-IIb fluorescence-image guided synergistic surgery/starvation/chemodynamic therapy: an innovative treatment paradigm for malignant non-small cell lung cancers.
Han X; Zhong Y; Mi C; He Z; Gu J; Dai X; Ma C; Feng C; Chen H; Lan Z; Guo Z; Huang L; Zhang B; Guo B; Meng Q
Theranostics; 2023; 13(7):2176-2191. PubMed ID: 37153731
[No Abstract] [Full Text] [Related]
7. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
8. Upregulation of NDUFAF2 in lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker.
Zou K; Gao P; Xu X; Zhang W; Zeng Z
Comput Math Methods Med; 2023; 2023():2912968. PubMed ID: 36703939
[TBL] [Abstract] [Full Text] [Related]
9. LINC00958: A promising long non-coding RNA related to cancer.
Li H; Gao J; Liu L; Zhang S
Biomed Pharmacother; 2022 Jul; 151():113087. PubMed ID: 35569349
[TBL] [Abstract] [Full Text] [Related]
10. SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution.
Sun S; Li Q; Zhang Z; Xiong S; Zhang Y; Liu Q; Li Z; Yang F; Zhang S
Environ Health Prev Med; 2022; 27():3. PubMed ID: 35289322
[TBL] [Abstract] [Full Text] [Related]
11. Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy.
Zhu Y; Yan C; Wang X; Xu Z; Lv J; Xu X; Yu W; Zhou M; Yue L
Cancer Biol Ther; 2022 Dec; 23(1):104-111. PubMed ID: 35239432
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a prognostic immune-related signature for small cell lung cancer.
Xie Q; Chu H; Yi J; Yu H; Gu T; Guan Y; Liu X; Liang J; Li Y; Wang J
Cancer Med; 2021 Dec; 10(24):9115-9128. PubMed ID: 34741430
[TBL] [Abstract] [Full Text] [Related]
13.
Zhu G; Shi R; Li Y; Zhang Z; Xu S; Chen C; Cao P; Zhang H; Liu M; Pan Z; Liu H; Chen J
Front Immunol; 2021; 12():670040. PubMed ID: 34512623
[TBL] [Abstract] [Full Text] [Related]
14. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer.
Chen Y; Zitello E; Guo R; Deng Y
Clin Transl Med; 2021 Apr; 11(4):e367. PubMed ID: 33931980
[TBL] [Abstract] [Full Text] [Related]
15. [Research Progress of Anti-angiogenic Agents Combined with Immunotherapy
in Patients with Advanced Non-small Cell lung cancer].
Wang J; Peng W; Jiang M; Wu L
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):196-203. PubMed ID: 33819970
[TBL] [Abstract] [Full Text] [Related]
16. [Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques
in the lung cancer Immunotherapy].
Sun W; Zhou J; Zhou J
Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):36-42. PubMed ID: 33478189
[TBL] [Abstract] [Full Text] [Related]
17. Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.
Sun D; Tian L; Zhu Y; Wo Y; Liu Q; Liu S; Li H; Hou H
Mol Med; 2020 Aug; 26(1):78. PubMed ID: 32791957
[TBL] [Abstract] [Full Text] [Related]
18. Diabetes insipidus and panhypopituitarism as a first presentation of silent adenocarcinoma of lung: a case report and literature review.
Sirinvaravong S; Vibhatavata P; Chunharojrith P; Cheunsuchon P; Sriussadaporn S
BMC Endocr Disord; 2019 Oct; 19(1):114. PubMed ID: 31664980
[TBL] [Abstract] [Full Text] [Related]
19. Radiogenomics: bridging imaging and genomics.
Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
[TBL] [Abstract] [Full Text] [Related]
20. NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.
Sottile R; Tannazi M; Johansson MH; Cristiani CM; Calabró L; Ventura V; Cutaia O; Chiarucci C; Covre A; Garofalo C; Pontén V; Tallerico R; Frumento P; Micke P; Maio M; Kärre K; Carbone E
Int J Cancer; 2019 Oct; 145(8):2238-2248. PubMed ID: 31018250
[TBL] [Abstract] [Full Text] [Related]
[Next]
